Your browser doesn't support javascript.
loading
Defining drug-resistant epilepsy
Neurology Asia ; : 67-69, 2011.
Article Dans Anglais | WPRIM | ID: wpr-628834
ABSTRACT
Drug resistant epilepsy remains a major clinical challenge. Diverse criteria have been used to defi ne drug resistance by different researchers, making it diffi cult or even impossible to compare the results across different studies. To improve patient care and facilitate clinical research, the International League Against Epilepsy recently proposed a consensus defi nition to defi ne drug resistant epilepsy as failure of adequate trials of two tolerated, appropriately chosen and used antiepileptic drug schedules (whether as monotherapies or in combination) to achieve sustained seizure freedom. This article outlines the framework of the consensus defi nition, explains how to apply it in practice, and discusses the future development in its use.
Texte intégral: Disponible Indice: WPRIM (Pacifique occidental) langue: Anglais Texte intégral: Neurology Asia Année: 2011 Type: Article

Documents relatifs à ce sujet

MEDLINE

...
LILACS

LIS

Texte intégral: Disponible Indice: WPRIM (Pacifique occidental) langue: Anglais Texte intégral: Neurology Asia Année: 2011 Type: Article